EXAGEN INC. (XGN) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 13.46M USD | Liabilities, Current |
| Cash and equivalents | 24.59M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 12.41M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $13.46M | $24.59M | (m) | $12.41M | (m) | (m) |
| 2026-03-31 | (m) | $12.56M | $21.51M | (m) | $15.77M | (m) | (m) |
| 2025-12-31 | (m) | $14.16M | $32.22M | (m) | $10.86M | (m) | (m) |
| 2025-09-30 | (m) | $12.89M | $35.65M | (m) | $11.09M | (m) | (m) |
| 2025-06-30 | (m) | $10.29M | $30.03M | (m) | $14.27M | (m) | (m) |
| 2025-03-31 | (m) | $13.99M | $11.19M | (m) | $14.73M | (m) | (m) |
| 2024-12-31 | (m) | $13.51M | $22.04M | (m) | $7.83M | (m) | (m) |
| 2024-09-30 | (m) | $8.78M | $22.04M | (m) | $9.39M | (m) | (m) |
| 2024-06-30 | (m) | $9.45M | $24.48M | (m) | $11.70M | (m) | (m) |
| 2024-03-31 | (m) | $8.78M | $27.27M | (m) | $10.90M | (m) | (m) |
| 2023-12-31 | (m) | $11.90M | $36.49M | (m) | $6.55M | (m) | (m) |
| 2023-09-30 | (m) | $10.12M | $28.45M | (m) | $17.04M | (m) | (m) |
| 2023-06-30 | (m) | $8.60M | $31.47M | (m) | $16.23M | (m) | (m) |
| 2023-03-31 | (m) | $9.27M | $52.18M | (m) | $9.30M | (m) | (m) |
| 2022-12-31 | (m) | $9.62M | $62.39M | (m) | $6.08M | (m) | (m) |
| 2022-09-30 | (m) | $11.33M | $68.70M | (m) | $10.64M | (m) | (m) |
| 2022-06-30 | (m) | $9.57M | $76.39M | (m) | $9.59M | (m) | (m) |
| 2022-03-31 | (m) | $11.88M | $89.75M | (m) | $10.91M | (m) | (m) |
| 2021-12-31 | (m) | $9.32M | $99.44M | (m) | $9.65M | (m) | (m) |
| 2021-09-30 | (m) | $8.10M | $106.77M | (m) | $9.21M | (m) | (m) |
| 2021-06-30 | (m) | $8.27M | $112.58M | (m) | $8.78M | (m) | (m) |
| 2021-03-31 | (m) | $7.88M | $118.05M | (m) | $8.22M | (m) | (m) |
| 2020-12-31 | (m) | $8.77M | $57.45M | (m) | $8.91M | (m) | (m) |
| 2020-09-30 | (m) | $8.27M | $61.43M | (m) | $9.30M | (m) | (m) |
| 2020-06-30 | (m) | $5.75M | $63.70M | (m) | $7.26M | (m) | (m) |
| 2020-03-31 | (m) | $7.33M | $68.65M | (m) | $5.84M | (m) | (m) |
| 2019-12-31 | (m) | $5.89M | $72.08M | (m) | $5.71M | (m) | (m) |
| 2019-09-30 | (m) | $7.66M | $77.83M | (m) | $6.24M | (m) | (m) |
| 2018-12-31 | (m) | $8.95M | $13.16M | (m) | $5.95M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |